Skip to main content

Gonzalo González Silva

Institutions of which they are part

Predoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Gonzalo González Silva

Institutions of which they are part

Predoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Related news

Docetaxel, carried by Soluplus, proved to be the most effective and least toxic combination to cross the blood-brain barrier and attack the tumour directly.

Based on the study led by VHIR, a clinical trial has been approved for patients with locally advanced pancreatic cancer.

Vall d'Hebron participates in a project to develop innovative microsampling technology, making blood collection more accessible and patient-centered.

Related professionals

Morales Sala, Cristina

Morales Sala, Cristina

Multidisciplinary Nursing Research Group
Read more
Pascual González, Gabriel

Pascual González, Gabriel

Cardiovascular Diseases
Read more
Palau Continente, Dolors

Palau Continente, Dolors

Genetics Medicine
Read more
Navarro Alonso, Marta

Navarro Alonso, Marta

Infectious Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.